7:04 PM
 | 
Nov 06, 2006
 |  BC Extra  |  Company News

Abbott to acquire Kos

KOSP gained $26.97 (54%) to $77.06 on Monday after ABT announced plans to acquire the cardiovascular, metabolic and pulmonary company for $78 per share, or about $3.7 billion in cash. The takeout price represents a 56% premium to KOSP's close...

Read the full 176 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >